Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Leukemia, T-Cell

morpholinoanthracycline mx2 has been researched along with Leukemia, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, XF; Kantharidis, P; Parkin, JD; Rischin, D; Slater, A; Zalcberg, J	1

Other Studies

1 other study(ies) available for morpholinoanthracycline mx2 and Leukemia, T-Cell

Article	Year
Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line. British journal of cancer, 1999, Volume: 79, Issue:5-6 Topics: Anthracyclines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carubicin; Cell Survival; Clone Cells; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Gene Expression Regulation, Neoplastic; Humans; Idarubicin; Kinetics; Leukemia, T-Cell; Structure-Activity Relationship; Tumor Cells, Cultured	1999

Article

Year

Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.

British journal of cancer, 1999, Volume: 79, Issue:5-6

Topics: Anthracyclines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carubicin; Cell Survival; Clone Cells; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Gene Expression Regulation, Neoplastic; Humans; Idarubicin; Kinetics; Leukemia, T-Cell; Structure-Activity Relationship; Tumor Cells, Cultured

1999